https://www.selleckchem.com/pr....oducts/PHA-665752.ht
65 ± 0.07 mg/mL. This study assessed adherence to, feasibility of, and barriers and facilitators of implementation of an app developed to monitor and follow-up with pain in children with cancer at home. Children (8-18years) receiving cancer treatment (all diagnoses) or their parents (of children aged 0-7years) used the KLIK Pain Monitor app for 3weeks. Pain was assessed twice daily using an 11-point numeric rating scale (NRS-11) (ranging from 0 to 1. Healthcare professionals (HCP's) from the hospital's Pediatric Pain Service were i
Like
Comment
Share
